Article
A native antigen "reverse capture" microarray platform for autoantibody profiling of prostate cancer sera.
2007-05-01
Abstract excerpt
Cancer sera contain antibodies that react with autologous cellular antigens. Here, we report the use of a novel native antigen-based platform, the "reverse capture" autoantibody microarray, for identification of autoantigens against which autoantibody expression may be used to differentiate between patients with prostate cancer and benign prostate hyperplasia (BPH). Serum samples were collected at our institution...
Topics
Open a Topic to create a Post that cites this publication.
- Advanced Biosensing Techniques and Applications
- Advanced Proteomics Techniques and Applications
- Gene expression and cancer classification
- Glycosylation and Glycoproteins Research
- Immunotherapy and Immune Responses
- Monoclonal and Polyclonal Antibodies Research
- Prostate Cancer Treatment and Research
- Proteoglycans and glycosaminoglycans research
Identifiers and source
- Literature Corpus work
- 49eb4c16-2904-555c-a57a-cd243ef4b2c3
- DOI
- 10.1002/prca.200700012
